Información del producto
UK 432097 is a small molecule drug that has been shown to reduce the effects of ischemia reperfusion injury in the tibial section model. The compound reduces inflammation and damage to tissues by binding to ATP-binding cassette transporters and prevents these proteins from transporting inflammatory cells into the site of injury. UK 432097 also binds to adenosine receptors, which are found on human macrophages, and prevents these cells from releasing pro-inflammatory cytokines. This drug also blocks adenosine receptor subtypes A1 and A2A, which have been shown to play a role in immunosuppression. The safety profile of this drug has been evaluated in animals and human serum samples, with no adverse effects seen. Crystallization process: Direct crystallization
Propiedades químicas
Consulta técnica sobre: 3D-FQA22163 UK 432097
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
